220798-52-7 Usage
General Description
3-Bromomethylbenzenesulfonamide is a chemical compound that contains a benzene ring with a sulfonamide group and a bromomethyl substituent. It is commonly used as a reagent in organic synthesis reactions, particularly in the production of pharmaceuticals and agrochemicals. 3-Bromomethylbenzenesulfonamide is known for its potential as a potent antibiotic and antifungal agent, making it valuable in the development of new drugs. Its unique chemical structure and reactivity make it a versatile building block for the creation of diverse molecular structures, making it a valuable tool in the field of medicinal chemistry and drug discovery. Additionally, 3-Bromomethylbenzenesulfonamide has been investigated for its potential use in the treatment of various medical conditions, further demonstrating its importance as a versatile and potentially valuable chemical compound.
Check Digit Verification of cas no
The CAS Registry Mumber 220798-52-7 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 2,2,0,7,9 and 8 respectively; the second part has 2 digits, 5 and 2 respectively.
Calculate Digit Verification of CAS Registry Number 220798-52:
(8*2)+(7*2)+(6*0)+(5*7)+(4*9)+(3*8)+(2*5)+(1*2)=137
137 % 10 = 7
So 220798-52-7 is a valid CAS Registry Number.
InChI:InChI=1/C7H8BrNO2S/c8-5-6-2-1-3-7(4-6)12(9,10)11/h1-4H,5H2,(H2,9,10,11)
220798-52-7Relevant articles and documents
INHIBITORS OF α-AMINO-β-CARBOXYMUCONIC ACID SEMIALDEHYDE DECARBOXYLASE
-
, (2020/06/10)
The present disclosure discloses compounds capable of modulating the activity of α-amino-β-carboxymuconic acid semialdehyde decarboxylase (ACMSD), which are useful for the prevention and/or the treatment of diseases and disorders associated with defects in NAD+ biosynthesis, e.g., metabolic disorders, neurodegenerative diseases, chronic inflammatory diseases, kidney diseases, and diseases associated with ageing. The present application also discloses pharmaceutical compositions comprising said compounds and the use of such compounds as a medicament.
NOVEL PIPERIDINE DERIVATIVE
-
Page/Page column 92, (2008/06/13)
The invention provides a compound of the following formula (1): wherein m, n, and p are independently an integer of 0 - 4, provided 3 ≤ m + n ≤ 8; X is nitrogen atom or a group of the formula: C-R15; Y is a substituted or unsubstituted aromatic group, etc.; R15, R1, R2, R3, R4 , R5, R6 and R7 are hydrogen atom, a substituted or unsubstituted alkyl group, etc.; and Z is hydrogen atom, cyano group, etc., or a prodrug thereof, or a pharmaceutically acceptable salt thereof, which exhibits an action for enhancing LDL receptor expression, and is useful as a medicament for treating hyperlipidemia, atherosclerosis, etc.
